Tailored immunosuppression after kidney transplantation - a single center real-life experience.

Miriam Good-WeberMalgorzata RoosThomas F MuellerBarbara RüsiThomas Hans Fehr

Published in: BMC nephrology (2020)

We observed excellent overall mid-term patient and graft survival rates with our tailored immunosuppression approach. Induction with thymoglobulin was efficient and safe in keeping rejection rates low in DSA positive patients with a negative CDC-XM.

Keyphrases

smoking cessation
case report